As Head of Total Rewards & HR Ops, Sharon will oversee the strategy and execution of the company’s compensation, benefits, people analytics and HR operations programs. In this role, Sharon will report directly to Chief People Officer Andrea Walton. Prior to joining bluebird bio, Sharon served as Senior Director, Total Rewards and People Operations at Butterfly Network, Inc.
bluebird bio is a biotech company leading clinical and research programs for sickle cell disease, beta-thalassemia and cerebral adrenoleukodystrophy, and it is actively advancing research to apply new technologies to these and other diseases. The company custom designs each of its therapies to address the underlying cause of disease and has developed in-depth and effective analytical methods to understand the safety of its lentiviral vector technologies and drive the field of gene therapy forward. bluebird now has the largest and deepest ex-vivo gene therapy data set in the world, setting the standard for the industry. Headquartered in Somerville, Massachusetts, bluebird has more than 375 employees and is listed on the NASDAQ as BLUE, with a market cap of nearly $400 million.